Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease (Q80356660)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 01 July 2004

Language	Label	Description	Also known as
English	Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease	scientific article published on 01 July 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

based on heuristic

inferred from title

clear cell carcinoma

1 reference

based on heuristic

inferred from title

author name string

Chih-Ming Ho

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Yun-Ju Huang

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Tze-Chien Chen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Shih-Hung Huang

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Fu-Shing Liu

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Chan-Chao Chang Chien

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Mu-Hsien Yu

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Tsui-Lien Mao

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Tao-Yeuan Wang

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Chang-Yao Hsieh

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 July 2004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

94

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

197-203

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Clear cell carcinoma of the ovary: A clinicopathologic study with review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Evaluation of complete surgical staging with pelvic and para-aortic lymphadenectomy and paclitaxel plus carboplatin chemotherapy for improvement of survival in stage I ovarian clear cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Allelotype analysis of common epithelial ovarian cancers with special reference to comparison between clear cell adenocarcinoma with other histological types

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Survival probability in ovarian clear cell adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Establishment and characterization of two human ovarian clear cell adenocarcinoma lines from metastatic lesions with different properties

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Cyclophosphamide and 5-fluorouracil act synergistically in ovarian clear cell adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Sensitivity to anticancer agents and resistance mechanisms in clear cell carcinoma of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Mechanisms of cisplatin resistance in clear cell carcinoma of the ovary.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

Endometrioid and clear cell carcinoma of the ovary. Factors affecting survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.04.004

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YGYNO.2004.04.004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15262142%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80356660&oldid=1757995796"